Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Boehringer Ingelheim

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Boehringer Ingelheim's 2013 sales performance.

Boehringer Ingelheim GmbH

Boehringer bolsters NASH pipeline with Enleofen link-up

Boehringer bolsters NASH pipeline with Enleofen link-up

Boehringer Ingelheim has added another platform in its fibrotic disease R&D, partnering with Enleofen on preclinical-stage interleukin-11 inhibitors with potential in non-alcoholic steatohepatitis (NASH). ... Ofev is already a blockbuster seller for

EU, US biotechs merge to create fibrosis, cancer player

EU, US biotechs merge to create fibrosis, cancer player Esbriet has since been joined on the market by Boehringer Ingelheim's Ofev (nintedanib), approved in 2014, with other new agents in trials including AstraZeneca’s saracatinib, Galapagos’ GLPG1690 and

AstraZeneca’s heart failure drug Farxiga scores FDA priority review

AstraZeneca’s heart failure drug Farxiga scores FDA priority review AZ is hoping to make some gains on SGLT2 inhibitor market leader Jardiance (empagliflozin) from Eli Lilly and Boehringer Ingelheim. ... Boehringer and Lilly are also testing Jardiance in both HFrEF and EFpEF with two trials – EMPEROR-Reduced and EMPEROR

Merck strengthens KRAS stake with Taiho and Astex partnership

Merck strengthens KRAS stake with Taiho and Astex partnership Other competitors in the KRAS inhibitor race include Mirati, Boehringer Ingelheim, Johnson &Johnson/Wellspring and AstraZeneca/Ionis.

Boehringer Ingelheim to manufacture first biologic in China under new reforms

Boehringer Ingelheim to manufacture first biologic in China under new reforms German pharma will manufacture BeiGene's PD-1 inhibitor. German pharma Boehringer Ingelheim will be the first company in China to manufacture a biologic, under new regulations aimed at accelerating the ... We are very proud to become the first company

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

David Atkins
A snapshot of Congenica
PME talks to CEO David Atkins...
Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...

Infographics